Related references
Note: Only part of the references are listed.Celastrol strongly inhibits proliferation, migration and cancer stem cell properties through suppression of Pin1 in ovarian cancer cells
Xiaojing Li et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Celastrol ameliorates acetaminophen-induced oxidative stress and cytotoxicity in HepG2 cells
A. T. Jannuzzi et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2018)
Inhibition effect of triptolide on human epithelial ovarian cancer via adjusting cellular immunity and angiogenesis
Hui Hu et al.
ONCOLOGY REPORTS (2018)
Ovarian Cancer Statistics, 2018
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
miR-33a-5p enhances the sensitivity of lung adenocarcinoma cells to celastrol by regulating mTOR signaling
You-Jie Li et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
Inhibition of WEE1 Suppresses the Tumor Growth in Laryngeal Squamous Cell Carcinoma
Meng-Ling Yuan et al.
FRONTIERS IN PHARMACOLOGY (2018)
Radiation Treatment in Women with Ovarian Cancer: Past, Present, and Future
Emma C. Fields et al.
FRONTIERS IN ONCOLOGY (2017)
Walsuronoid B induces mitochondrial and lysosomal dysfunction leading to apoptotic rather than autophagic cell death via ROS/p53 signaling pathways in liver cancer
Ya-di Geng et al.
BIOCHEMICAL PHARMACOLOGY (2017)
Targeting acute myeloid leukemia with a small molecule inhibitor of the Myb/p300 interaction
Sagar Uttarkar et al.
BLOOD (2016)
The ROS derived mitochondrial respirstion not from NADPH oxidase plays key role in Celastrol against angiotensin II-mediated HepG2 cell proliferation
Xin Liu et al.
APOPTOSIS (2016)
Sequential combination therapy of ovarian cancer with cisplatin and γ-secretase inhibitor MK-0752
XiuXiu Chen et al.
GYNECOLOGIC ONCOLOGY (2016)
Enhancement of triptolide-loaded micelles on tumorigenicity inhibition of human ovarian cancer
You Wang et al.
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION (2016)
Effects of celastrol on enhancing apoptosis of ovarian cancer cells via the downregulation of microRNA-21 and the suppression of the PI3K/Akt-NF-κB signaling pathway in an in vitro model of ovarian carcinoma
Haiyan Zhang et al.
MOLECULAR MEDICINE REPORTS (2016)
Celastrol Ameliorates Ulcerative Colitis-Related Colorectal Cancer in Mice via Suppressing Inflammatory Responses and Epithelial-Mesenchymal Transition
Lianjie Lin et al.
FRONTIERS IN PHARMACOLOGY (2016)
Treatment of Obesity with Celastrol
Junli Liu et al.
CELL (2015)
Phosphonooxymethyl Prodrug of Triptolide: Synthesis, Physicochemical Characterization, and Efficacy in Human Colon Adenocarcinoma and Ovarian Cancer Xenografts
Satish Patil et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Celastrol induces apoptosis and autophagy via the ROS/JNK signaling pathway in human osteosarcoma cells: an in vitro and in vivo study
H-Y Li et al.
CELL DEATH & DISEASE (2015)
Cyclin-dependent kinase inhibitor dinaciclib potently synergizes with cisplatin in preclinical models of ovarian cancer
Xiu-Xiu Chen et al.
ONCOTARGET (2015)
Synergistic anticancer effects of triptolide and celastrol, two main compounds from thunder god vine
Qi-Wei Jiang et al.
ONCOTARGET (2015)
Cables1 Complex Couples Survival Signaling to the Cell Death Machinery
Zhi Shi et al.
CANCER RESEARCH (2015)
Celastrol inhibits the HIF-1α pathway by inhibition of mTOR/p70S6K/eIF4E and ERK1/2 phosphorylation in human hepatoma cells
Juan Ma et al.
ONCOLOGY REPORTS (2014)
Piperlongumine Induces Apoptosis and Synergizes with Cisplatin or Paclitaxel in Human Ovarian Cancer Cells
Li-Hua Gong et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2014)
Advances in tumor screening, imaging, and avatar technologies for high-grade serous ovarian cancer
Anders W. Ohman et al.
FRONTIERS IN ONCOLOGY (2014)
Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?
Simran S. Sabharwal et al.
NATURE REVIEWS CANCER (2014)
The antioxidant paradox: less paradoxical now?
Barry Halliwell
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Tripterygium wilfordii bioactive compounds as anticancer and anti-inflammatory agents
Kwong-Fai Wong et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2012)
Triptolide inhibits ovarian cancer cell invasion by repression of matrix metalloproteinase 7 and 19 and upregulation of E-cadherin
Hongxi Zhao et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2012)
Celastrol inhibits tumor cell proliferation and promotes apoptosis through the activation of c-Jun N-terminal kinase and suppression of PI3 K/Akt signaling pathways
Radhamani Kannaiyan et al.
APOPTOSIS (2011)
Celastrol targets mitochondrial respiratory chain complex I to induce reactive oxygen species-dependent cytotoxicity in tumor cells
Guozhu Chen et al.
BMC CANCER (2011)
Unraveling the Biological Roles of Reactive Oxygen Species
Michael P. Murphy et al.
CELL METABOLISM (2011)
Celastrol, a triterpene extracted from the Chinese Thunder of God Vine, is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice
Huanjie Yang et al.
CANCER RESEARCH (2006)
Reversal of MDR1/P-glycoprotein-mediated multidrug resistance by vector-based RNA interference in vitro and in vivo
Z Shi et al.
CANCER BIOLOGY & THERAPY (2006)
Share Paper
